Saving changes...

Done

Error

First-line Use of Antiretrovirals - HIV

First-line Use of Antiretrovirals - HIV

First-line Use of Antiretrovirals - HIV

Laura Waters , John Evans-Jones and David Asboe
Laura Waters , John Evans-Jones and David Asboe
on behalf of Health Education England

$30.00 $ 30.00 $ 30.00

$ 30.00 $ 30.00 $ 30.00
$ 30.00 $ 30.00 $ 30.00
Normal Price: $30.00 $30.00

Review:

Launch date: 09 Aug 2018
Expiry Date:

Last updated: 16 Oct 2019

Reference: 191704

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

Fredrick Mutisya (16 Oct 2019)
Excessive use of Drug Brand names.

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

This session discusses the indications to start antiretroviral therapy (ART), and presents guidelines for first time ART use. Recommended treatments are discussed and the individualisation of treatment is explained.

Objectives

By the end of this session you will be able to:
• Explain the current recommendations for commencing ART
• Outline the regimens recommended for first-line ART
• Compare recommended 3rd agents
• Describe indications and contraindications for using Kivexa ® versus Truvada ® as the NRTI backbone
• Explain how different ART regimens should be used in different groups
• Explain how individuals should be initially monitored after commencement of ART
Laura Waters , John Evans-Jones and David Asboe

Author Information Play Video Bio

Laura Waters , John Evans-Jones and David Asboe
on behalf of Health Education England

Laura Waters -
HIV & Hepatitis Service Lead, Mortimer Market Centre, London

Laura Waters is a GU/HIV consultant at the Mortimer Market Centre, London, working predominantly in HIV and hepatitis outpatient services; she is HIV & Hepatitis Service Lead. She has worked in clinical trials in Brighton and Chelsea & Westminster where she completed an MD in antiretroviral switch. She is chair of the BHIVA ART guidelines and was vice-chair for the 2015 version. She is chair of the BASHH HIV special interest group organising the annual Masterclass and Focus meetings, was an author on the 2015 BASHH PEPSE guidelines and is chairing the upcoming update of the BHIVA/BASHH/FSRH SRH guidelines for PLWH. Laura is on the HIV CRG and the CRG drugs sub-group. She is principle investigator on several ARV trials. She has published and presented widely on topics including drug toxicity and contraception for HIV-positive women.


John Evans-Jones -
John Evans-Jones is a Consultant in Genitourinary Medicine (GUM) based in Chester, who does clinical work for both East Cheshire NHS Trust and the Countess of Chester Hospital.

His undergraduate training was at the University of Sheffield, with postgraduate specialist training in GUM following in both London and Liverpool. He has been Clinical Lead for eHIV-STI since 2014, having previously been a registrar representative on the project executive. He is also significantly involved in the Mersey, Cheshire and North Wales HIV Managed Care Network, co-chairing the perinatal HIV group.

He is local Principle Investigator for a number of National Institute for Health Research (NIHR) portfolio studies and is a member of the Health Education North West Speciality Training Committee for GUM.



David asboe -
Consultant in Sexual Health and HIV Medicine, Chelsea and Westminster Hospital, London

David Asboe, qualified in New Zealand and did his specialist training in the UK. He is a consultant in Sexual Health and HIV Medicine at Chelsea and Westminster Hospital, London. He chairs the Trust’s Virtual Antiretroviral Advice Clinic and has research interests including sexual health of HIV positive individuals and antiretroviral resistance. He is currently the convenor of the Diploma HIV Medicine exam and serves on the executive committee of the British HIV Association.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Health Education England
  • 0.75 Units -
    Exam Pass Rate: 60

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (1)

Go Back
Fredrick Mutisya (16 Oct 2019)
Excessive use of Drug Brand names.

Loading...


Saving changes...

Done

Error